1. Home
  2. SFL vs OCUL Comparison

SFL vs OCUL Comparison

Compare SFL & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SFL Corporation Ltd

SFL

SFL Corporation Ltd

N/A

Current Price

$12.47

Market Cap

1.6B

ML Signal

N/A

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

N/A

Current Price

$10.90

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SFL
OCUL
Founded
2003
2006
Country
Bermuda
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
SFL
OCUL
Price
$12.47
$10.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
9
Target Price
$12.00
$23.56
AVG Volume (30 Days)
1.2M
2.6M
Earning Date
05-13-2026
05-05-2026
Dividend Yield
7.05%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,990,000.00
Revenue This Year
N/A
$7.93
Revenue Next Year
$13.07
$96.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.48
52 Week Low
$6.73
$6.23
52 Week High
$12.94
$16.44

Technical Indicators

Market Signals
Indicator
SFL
OCUL
Relative Strength Index (RSI) 59.01 60.22
Support Level $11.89 $7.96
Resistance Level $12.86 $11.62
Average True Range (ATR) 0.31 0.49
MACD -0.02 -0.03
Stochastic Oscillator 65.19 58.50

Price Performance

Historical Comparison
SFL
OCUL

About SFL SFL Corporation Ltd

SFL Corp Ltd is an international ship-owning and chartering company. The company is engaged in transporting crude oil and oil products, dry bulk and containerized cargoes, freight of rolling cargo, and offshore drilling and related activities. The company operates as a single reportable segment, generating revenue from long-term, fixed-rate charters. Its Additional revenue sources include sales-type lease interest income, voyage charter and pool revenues, and drilling contract revenues.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: